Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Introducing MenACWY adolescent vaccination in Germany could significantly reduce invasive meningococcal disease (IMD) cases and deaths, unlike MenC vaccines. This strategy offers substantial public health benefits and potential economic advantages.
Area Of Science
- Epidemiology
- Vaccinology
- Public Health
Background
- Invasive meningococcal disease (IMD) poses a significant threat with high mortality and long-term sequelae.
- Germany's current immunization program primarily uses MenC vaccines in toddlers.
Purpose Of The Study
- To assess the public health impact of MenACWY and MenC adolescent vaccination strategies in Germany.
- To compare the effectiveness of MenACWY versus MenC vaccines in reducing IMD.
Main Methods
- A dynamic transmission model simulated meningococcal serogroup carriage (AY/B/C/W/Other) from 2019-2060.
- Estimated IMD cases using case-carrier ratios, considering vaccine effectiveness against carriage and disease.
Main Results
- MenACWY adolescent vaccination could prevent up to 1467 IMD cases and 156 deaths by 2060, yielding 2250 life years gained.
- Herd effects from MenACWY vaccination reduce IMD incidence across all age groups.
- MenC adolescent vaccination showed minimal impact on IMD incidence, mortality, and life years gained.
Conclusions
- MenACWY adolescent vaccination is projected to significantly decrease IMD incidence and mortality in Germany.
- MenC adolescent vaccination is unlikely to provide substantial public health benefits.
- MenACWY vaccination may offer economic advantages, meriting cost-effectiveness analysis.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
